Celltrion launches autoimmune disease treatment in US

Govt treats 42.01 mn for hypertension, 25.27 mn for diabetes under ‘75 by 25’ initiative

Govt committed to improving cancer care, treatment accessibility: Prataprao Jadhav

Indian pharma market to grow 8-9 per cent in FY26: Report

S.Korean drugmaker Celltrion gets USFDA approval for allergic asthma biosimilar

VP Jagdeep Dhankhar Hospitalized at AIIMS Delhi for Heart-Related Monitoring

Ayushman Bharat made commendable progress in gender equity in healthcare: Experts

Bryan Johnson injects ketamine into his brain, claiming it “scrambled” his mind.

Celltrion's autoimmune disease treatment gets approval in Europe

Insurance Premiums to be set based on health factors, companies preparing for change

India no longer dependent on foreign aid or funding for tackling AIDS: NACO

Study calls out against spine injections for chronic back pain